Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.12g/L equivalent to Noradrenaline base 0.06g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2014.
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.199g/L equivalent to Noradrenaline base 0.1g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2014.
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.239g/L equivalent to Noradrenaline base 0.12g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2014.
Product: Noradrenaline Tartrate
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.319g/L equivalent to Noradrenaline base 0.16g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 2 December 2014.
Dated this 22nd day of August 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).